1999
DOI: 10.1097/00006250-199908000-00025
|View full text |Cite
|
Sign up to set email alerts
|

Preterm Labor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 14 publications
0
3
0
Order By: Relevance
“…In the context of the role of GPR18 as a receptor for the SPM RvD2, the expression of GPR18 on the vascular-associated cell types is of physiological significance, because appropriate vascular functioning is critical to maintain maternal-fetal health and prevent negative perinatal outcomes. Dysfunctions in placental vasculature increase risk for intrauterine growth restriction, preterm delivery, and pre-eclampsia [21,22,23,24]. While some studies aimed at finding molecular biomarkers for these complications, others focus on lipids.…”
Section: Discussionmentioning
confidence: 99%
“…In the context of the role of GPR18 as a receptor for the SPM RvD2, the expression of GPR18 on the vascular-associated cell types is of physiological significance, because appropriate vascular functioning is critical to maintain maternal-fetal health and prevent negative perinatal outcomes. Dysfunctions in placental vasculature increase risk for intrauterine growth restriction, preterm delivery, and pre-eclampsia [21,22,23,24]. While some studies aimed at finding molecular biomarkers for these complications, others focus on lipids.…”
Section: Discussionmentioning
confidence: 99%
“…This suggests that in PET cases, HPV oncoproteins affecting cell function likely occur in the placenta if high-risk HPV DNA is present [25,32]. In trophoblast cultures, the introduction of HPV influenced the resulting trophoblast phenotypes, which would impair implantation and placental maintenance that underpin PET [8,20,[33][34][35]; this was also observed in a study that only introduced E6 and E7 without the whole HPV genome [20].…”
Section: Discussionmentioning
confidence: 80%
“…In the FGR, diabetic, and HPV-positive control cohorts (Figure 4), HPV 18 was present in 67% (n = 6/9), 50% (n = 3/6), and 63% (n = 5/8) of cases with an HPV type identified, respectively. In all cohorts, the next most frequent HPV type was 16, followed by other high-risk types 33,35,39,45,52, and 66. Low-risk HPV types (42,55) and types of unclassified risk (26, 40, 53, 61, and 89) were also found amongst the cohorts.…”
Section: Hpv Types In the Pet Placentamentioning
confidence: 98%